QUAN CAPITAL MANAGEMENT, LLC
QUAN CAPITAL MANAGEMENT, LLC is a Series A, Series B and Series C+ fund in global and china writing $60M–$110M checks into Healthcare, pharma, oncology, immunology, rare-diseases, therapeutic-biotech-pharma, enabling-technologies, high-end-specialty-services, companion-diagnostics and precision-medicine.
- Stages
- Series A, Series B, Series C+
- Sectors
- Healthcare, pharma, oncology, immunology, rare-diseases, therapeutic-biotech-pharma, enabling-technologies, high-end-specialty-services, companion-diagnostics, precision-medicine
- Check size
- $60M–$110M
- Invests in
- global, china
- Actively investing
- Yes
- Founded
- 2017
- Assets under management
- $318M
Thesis
Quan Capital Management, LLC, founded in 2017, is a venture capital firm specializing in the life sciences sector, with a dual focus on global markets and China's innovation ecosystem. The firm's investment thesis targets early and growth-stage companies developing novel treatments and enabling technologies in therapeutic biotech/pharma, companion diagnostics, and precision medicine. Key areas of interest include oncology, immunology, and rare diseases. Quan Capital provides 'smart capital,' combining financial investment with scientific expertise, operational guidance, and extensive networks. They primarily invest in Series A and B rounds, though they are open to other early and growth stages. As of May 2026, the firm managed 3 private funds with a total gross asset value of $318 million and had a portfolio of 32 companies. Quan Capital operates as an Exempt Reporting Adviser (ERA) with the SEC and has offices in Shanghai and San Francisco.
Common questions
Does QUAN CAPITAL MANAGEMENT, LLC invest at the Series A stage?
Yes. QUAN CAPITAL MANAGEMENT, LLC lists Series A, Series B and Series C+ among the stages it invests in.
What check size does QUAN CAPITAL MANAGEMENT, LLC write?
QUAN CAPITAL MANAGEMENT, LLC writes $60M–$110M checks.
Where does QUAN CAPITAL MANAGEMENT, LLC invest?
QUAN CAPITAL MANAGEMENT, LLC invests in global and china.